Article
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.
International journal of cancer - 15 Oct 2012
Mohammed Altaf, Qian Li, Janakiram Naveena B, Lightfoot Stan, Steele Vernon E, Rao Chinthalapally V
Abstract excerpt
Pancreatic cancer is the one of most common causes of cancer deaths and has the worst prognosis. Clinical observational studies suggest that statins may reduce the risk of pancreatic cancer. The chemopreventive efficacy of the statin atorvastatin (Lipitor(®)) and the role of the phosphatidyl-inositol 3-kinase (PI3/AKT) signaling pathway were evaluated for the progression of pancreatic intraepithelial neoplasms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
